-
Sector Analysis
Infusion Pumps Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Infusion Pumps Market Overview The infusion pumps market size was valued at $2.64 billion in 2023. The infusion pumps market will grow at a CAGR of more than 2% from 2023 to 2033. The infusion pump is a commonly used medical device for patients with chronic conditions such as cancer and diabetes used at hospitals, homes, and healthcare centers. Infusion pumps successfully address the delivery-related problems that have serious implications on patient safety, with their ability to administer fluids, medication,...
-
Product Insights
NewLikelihood of Approval Analysis for Dilated Cardiomyopathy
Overview How likely is it that the drugs in Dilated Cardiomyopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dilated Cardiomyopathy Overview Dilated cardiomyopathy (DCM) is a condition in which the...
-
Product Insights
NewLikelihood of Approval Analysis for Systolic Heart Failure
Overview How likely is it that the drugs in Systolic Heart Failure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Systolic Heart Failure Overview Systolic heart failure is a cardiovascular disorder...
-
Product Insights
NewLikelihood of Approval Analysis for Peptic Ulcers
Overview How likely is it that the drugs in Peptic Ulcers will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peptic Ulcers Overview Peptic ulcers are open sores that develop on the...
-
Product Insights
NewLikelihood of Approval Analysis for Cardiomyopathy
Overview How likely is it that the drugs in Cardiomyopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cardiomyopathy Overview Cardiomyopathy a disease of the heart muscle, where the walls of...
-
Product Insights
NewLikelihood of Approval Analysis for Hypertrophic Cardiomyopathy
Overview How likely is it that the drugs in Hypertrophic Cardiomyopathy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypertrophic Cardiomyopathy Overview Hypertrophic cardiomyopathy (HCM) is a disease in which the...
-
Product Insights
NewLikelihood of Approval Analysis for Drug Toxicity
Overview How likely is it that the drugs in Drug Toxicity will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Drug Toxicity Overview Drug toxicity' can be defined as a diverse array...
-
Product Insights
NewLikelihood of Approval Analysis for Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Overview How likely is it that the drugs in Clostridioides difficile Infections (Clostridium difficile Associated Disease) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Clostridioides difficile Infections (Clostridium difficile Associated Disease)...
-
Product Insights
NewLikelihood of Approval Analysis for Hypertension
Overview How likely is it that the drugs in Hypertension will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypertension Overview Hypertension, commonly known as high blood pressure, is a chronic medical...
-
Product Insights
NewLikelihood of Approval Analysis for Hypersecretory Conditions
Overview How likely is it that the drugs in Hypersecretory Conditions will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hypersecretory Conditions Overview Hypersecretory Condition is a group of disorders characterized by...